Ming Sun1, Yumei Zhao, Chao Xu. 1. Department of Neurochemistry, Beijing Neurosurgical Institute, 6 Tiantan Xi Li, Chongwen District, 100050, Beijing, China.
Abstract
AIMS: Some data have shown the functional connection between calpain and caspase-3. Here, we investigated the cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion. METHODS: The activities of calpain and the levels of calpastatin, microtubule-associated protein-2 (MAP-2), and spectrin in penumbra and core at 3 or 23 h of reperfusion (R 3 h or R 23 h) after 1-h focal cerebral ischemia in rats were determined in sham- or caspase-3 inhibitor z-DEVD-CHO-treated rats.On the other hand, the determination of the activities of caspase-3 and the levels of MAP-2 and spectrin was done in sham- or calpain-inhibitor I-treated rats. RESULTS: z-DEVD-CHO (600 ng/rat, i.c.v.) markedly reduced the mu- and m-calpain activities in penumbra and the m-calpain activities in core at R 3 h and R 23 h, and enhanced the calpastatin levels in penumbra at R 3 h and in core at R 3 h and R 23 h significantly; however, it had no significant effects on the mu-calpain activities in core and the calpastatin levels in penumbra at R 23 h. Calpain inhibitor I (0.8 mg/rat, i.c.v.) markedly reduced the caspase-3 activities in core at R 3 h and R 23 h, but not in penumbra. Both calpain and caspase-3 inhibitors increased the levels of MAP-2 and spectrin in penumbra and core significantly after focal cerebral ischemia-reperfusion. CONCLUSIONS: Our data provide direct evidence to demonstrate the cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion.
AIMS: Some data have shown the functional connection between calpain and caspase-3. Here, we investigated the cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion. METHODS: The activities of calpain and the levels of calpastatin, microtubule-associated protein-2 (MAP-2), and spectrin in penumbra and core at 3 or 23 h of reperfusion (R 3 h or R 23 h) after 1-h focal cerebral ischemia in rats were determined in sham- or caspase-3 inhibitor z-DEVD-CHO-treated rats.On the other hand, the determination of the activities of caspase-3 and the levels of MAP-2 and spectrin was done in sham- or calpain-inhibitor I-treated rats. RESULTS:z-DEVD-CHO (600 ng/rat, i.c.v.) markedly reduced the mu- and m-calpain activities in penumbra and the m-calpain activities in core at R 3 h and R 23 h, and enhanced the calpastatin levels in penumbra at R 3 h and in core at R 3 h and R 23 h significantly; however, it had no significant effects on the mu-calpain activities in core and the calpastatin levels in penumbra at R 23 h. Calpain inhibitor I (0.8 mg/rat, i.c.v.) markedly reduced the caspase-3 activities in core at R 3 h and R 23 h, but not in penumbra. Both calpain and caspase-3 inhibitors increased the levels of MAP-2 and spectrin in penumbra and core significantly after focal cerebral ischemia-reperfusion. CONCLUSIONS: Our data provide direct evidence to demonstrate the cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion.
Authors: B L Schwab; D Guerini; C Didszun; D Bano; E Ferrando-May; E Fava; J Tam; D Xu; S Xanthoudakis; D W Nicholson; E Carafoli; P Nicotera Journal: Cell Death Differ Date: 2002-08 Impact factor: 15.828
Authors: H Hara; R M Friedlander; V Gagliardini; C Ayata; K Fink; Z Huang; M Shimizu-Sasamata; J Yuan; M A Moskowitz Journal: Proc Natl Acad Sci U S A Date: 1997-03-04 Impact factor: 11.205
Authors: T Ghayur; M Hugunin; R V Talanian; S Ratnofsky; C Quinlan; Y Emoto; P Pandey; R Datta; Y Huang; S Kharbanda; H Allen; R Kamen; W Wong; D Kufe Journal: J Exp Med Date: 1996-12-01 Impact factor: 14.307
Authors: Zhan-hui Feng; Junwei Hao; Lan Ye; Carlos Dayao; Ning Yan; Yong Yan; Lan Chu; Fu-dong Shi Journal: Seizure Date: 2011-02-10 Impact factor: 3.184
Authors: Marianne Nielsen; K L Lambertsen; B H Clausen; M Meldgaard; N H Diemer; J Zimmer; B Finsen Journal: Exp Brain Res Date: 2009-01-13 Impact factor: 1.972
Authors: Mala V Rao; Mary Kate McBrayer; Jabbar Campbell; Asok Kumar; Audrey Hashim; Henry Sershen; Philip H Stavrides; Masuo Ohno; Michael Hutton; Ralph A Nixon Journal: J Neurosci Date: 2014-07-09 Impact factor: 6.167
Authors: X J Lai; S Q Ye; L Zheng; L Li; Q R Liu; S B Yu; Y Pang; S Jin; Q Li; A C H Yu; X Q Chen Journal: Cell Death Dis Date: 2014-04-17 Impact factor: 8.469